PDT Partners’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-85,610
| Closed | -$199K | – | 716 |
|
|
2024
Q2 | $199K | Sell |
85,610
-103,418
| -55% | -$241K | 0.02% | 606 |
|
|
2024
Q1 | $845K | Buy |
189,028
+173,084
| +1,086% | +$774K | 0.08% | 366 |
|
|
2023
Q4 | $51.2K | Hold |
15,944
| – | – | 0.01% | 527 |
|
|
2023
Q3 | $50.5K | Buy |
+15,944
| New | +$50.5K | 0.01% | 569 |
|
|
2022
Q4 | – | Sell |
-112,701
| Closed | -$1.22M | – | 620 |
|
|
2022
Q3 | $1.22M | Sell |
112,701
-85,018
| -43% | -$918K | 0.18% | 166 |
|
|
2022
Q2 | $2.25M | Sell |
197,719
-43,873
| -18% | -$500K | 0.2% | 145 |
|
|
2022
Q1 | $2.2M | Buy |
241,592
+55,510
| +30% | +$506K | 0.19% | 149 |
|
|
2021
Q4 | $2.78M | Buy |
186,082
+127,355
| +217% | +$1.9M | 0.21% | 170 |
|
|
2021
Q3 | $1.51M | Sell |
58,727
-105,101
| -64% | -$2.7M | 0.11% | 288 |
|
|
2021
Q2 | $4.27M | Buy |
163,828
+82,563
| +102% | +$2.15M | 0.28% | 156 |
|
|
2021
Q1 | $2.87M | Sell |
81,265
-52,476
| -39% | -$1.85M | 0.21% | 206 |
|
|
2020
Q4 | $3.38M | Buy |
133,741
+36,798
| +38% | +$929K | 0.23% | 187 |
|
|
2020
Q3 | $3.66M | Buy |
+96,943
| New | +$3.66M | 0.24% | 158 |
|
|
2020
Q1 | – | Sell |
-15,640
| Closed | -$406K | – | 648 |
|
|
2019
Q4 | $406K | Buy |
+15,640
| New | +$406K | 0.03% | 464 |
|